DSE : ACTIVEFINE
Active Fine Chemicals Limited — Key statistics
Medicinal Chemicals and Botanical Products · Bangladesh
Last price 4.3 BDT (At close: Oct 28, 2026) · Market cap 1.03B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Technical report: trend, RSI, support and resistance, charts
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.06B |
| Enterprise Value | n/a |
Dates
| Measure | Value |
|---|
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 239.94M |
| Shares Outstanding | 239.94M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -47.56% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.78 |
| PB Ratio | 0.20 |
| P/TBV Ratio | 0.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 10.74 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.35 |
| Quick Ratio | 0.66 |
| Debt / Equity | 0.63 |
| Debt / EBITDA | 2.91 |
| Debt / FCF | n/a |
| Interest Coverage | 0.59 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -0.09% |
| Return on Assets (ROA) | 1.16% |
| Return on Invested Capital (ROIC) | -1.91% |
| Return on Capital Employed (ROCE) | 3.08% |
| Weighted Average Cost of Capital (WACC) | -4.83% |
| Revenue Per Employee | 14.70M |
| Profits Per Employee | -49,375 |
| Employee Count | 92 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 0.69 |
Taxes
| Measure | Value |
|---|
| Income Tax | 9.55M |
| Effective Tax Rate | 190.73% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.06 |
| 52-Week Price Change | -38.03% |
| 50-Day Moving Average | 5.52 |
| 200-Day Moving Average | 6.34 |
| Relative Strength Index (RSI) | 23.12 |
| Average Volume (20 Days) | 206,619 |
Shortselling
| Measure | Value |
|---|
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Incomestatement
| Measure | Value |
|---|
| Revenue | 1.35B |
| Gross Profit | 336.56M |
| Operating Income | 170.28M |
| Pretax Income | 5.01M |
| Net Income | -4.54M |
| EBITDA | 1.15B |
| EBIT | 170.28M |
| Loss Per Share | -0.02 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 569.52M |
| Total Debt | 3.34B |
| Net Cash | -2.77B |
| Net Cash Per Share | -11.56 |
| Equity (Book Value) | 5.32B |
| Book Value Per Share | 22.17 |
| Working Capital | 1.30B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 98.26M |
| Capital Expenditures | -377.06M |
| Depreciation & Amortization | 980.19M |
| Net Borrowing | 261.24M |
| Free Cash Flow | -278.81M |
| FCF Per Share | -1.16 |
Margins
| Measure | Value |
|---|
| Gross Margin | 24.89% |
| Operating Margin | 12.59% |
| Pretax Margin | 0.37% |
| Profit Margin | -0.34% |
| EBITDA Margin | 85.07% |
| EBIT Margin | 12.59% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | 0.03 |
| Dividend Yield | 0.57% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 3.39% |
| Shareholder Yield | 3.96% |
| Earnings Yield | -0.45% |
| FCF Yield | -26.41% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Nov 18, 2018 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.38 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |